Impact of P2Y₁₂ Inhibitor Pretreatment on Clinical Outcomes in ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study
{{output}}
Background: The benefit of P2Y₁₂ inhibitor pretreatment before primary percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) remains uncertain. ... ...
